EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Analysis at Hanusch Hospital, Vienna

Christoph Spartalis, Christoph Hackl, Stephan Radda, Oliver Findl

Klinische Monatsblätter für Augenheilkunde · 01.07.2026 · 243 (07) · 759-766

DOI: 10.1055/a-2772-8827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.07.2026. Verfasst von Christoph Spartalis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Hanusch Hospital, Vienna, Austria. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Photochemotherapy, Verteporfin. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic central serous chorioretinopathy (cCSC) is an exudative maculopathy characterised by persistent subretinal fluid and potential visual deterioration. Photodynamic therapy (PDT) with verteporfin is an established treatment option, particularly in refractory or chronic cases. This retrospective, single centre study aimed to evaluate the functional and morphological efficacy of PDT in patients with cCSC at Hanusch Hospital, Vienna. Patients/Materials and Methods We analysed 49 eyes of 38 patients who underwent PDT between 2020 and 2025. Best-corrected visual acuity (decimal), central retinal thickness (CRT, µm), and subretinal fluid (SRF, µm) were assessed using spectral domain OCT before and after treatment. Statistical analyses included the Shapiro-Wilk test for normality and the Wilcoxon signed-rank test for paired samples. Subgroup analyses were conducted for repeat PDT (Re-PDT) and secondary choroidal neovascularisation (CNV).

Results

Overall, PDT led to a significant improvement in visual acuity (p = 0.041) and a highly significant reduction in both CRT and SRF (each p < 0.001). In the Re-PDT subgroup (n = 6), significant morphological improvement (p = 0.028 for CRT and SRF) was observed without a statistically significant gain in vision (p = 0.109). No significant therapeutic effect was found in patients with secondary CNV. There was a significant negative correlation between visual acuity and CRT (r = − 0.42; p = 0.005) and between visual acuity and SRF (r = − 0.37; p = 0.012).

Conclusion

PDT appears to be an effective treatment for achieving anatomical and functional stabilisation in cCSC. The limited visual improvement in Re-PDT and CNV subgroups underscores the importance of early treatment and tailored decision-making in cases of secondary neovascularisation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyPhotochemotherapyVerteporfinHumansRetrospective StudiesMaleFemaleTreatment OutcomeVisual AcuityMiddle AgedPhotosensitizing AgentsAustriaChronic DiseaseAdultTomography, Optical CoherenceAged

Substanzen

VerteporfinPhotosensitizing Agents

Autor:innen und Institutionen

  • Ophthalmology, Hanusch Hospital, Vienna, Austria.

Zitieren

APA

Spartalis, C., Hackl, C., Radda, S., & Findl, O. (2026). Efficacy of Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Analysis at Hanusch Hospital, Vienna. Klinische Monatsblätter für Augenheilkunde, 243(07), 759-766. https://doi.org/10.1055/a-2772-8827

Vancouver

Spartalis C, Hackl C, Radda S, Findl O. Efficacy of Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Analysis at Hanusch Hospital, Vienna. Klinische Monatsblätter für Augenheilkunde. 2026;243(07):759-766. doi:10.1055/a-2772-8827

BibTeX
@article{Spartalis2026,
  author = {Spartalis, Christoph and Hackl, Christoph and Radda, Stephan and Findl, Oliver},
  title = {Efficacy of Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Analysis at Hanusch Hospital, Vienna},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2026},
  volume = {243},
  number = {07},
  pages = {759--766},
  doi = {10.1055/a-2772-8827}
}
Kostenlos starten →